> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Biosimilar User Fee Program
- URL: https://www.fdaweb.com/guide-on-biosimilar-user-fee-program/
- Published: 2018-06-29T12:00:00.000Z
- Updated: 2026-09-15T00:17:22.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141802

*Federal Register* notice: FDA has made available a final guidance entitled “Assessing User Fees Under the Biosimilar User Fee Amendments of 2017.” The document addresses FDA’s implementation of the biosimilar user fee program and certain changes in policies and procedures. To view the notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2018-06-29/pdf/2018-14049.pdf?ref=fdaweb.com)